Protara Therapeutics, Inc. (TARA) AI Dilution Summary

Cash was $142,494,000 at 2026-06-30, against estimated monthly burn of $6,122,000. The funding channel in place is an at-the-market program with TD Securities (USA) LLC (TD Cowen), authorised to $100,000,000, with $0 sold to date. Dilution here is driven primarily by that $100,000,000 ATM program.